Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03141034
Title Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma


Irinotecan + Ramucirumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.